We have demonstrated that research‐grade NPCs derived from CD patient iPSCs that were transduced with a wild type ASPA gene are able to ameliorate disease phenotypes in a CD (Nur7) mouse model in our developmental stage study. This evidence concerns the gene ASPA and Cowden disease.